Mp35-13 Prevalence, Trends, and Costs of Office-Based and Ambulatory Surgery Center-Based Diagnostic Cystoscopy in the United States

You have accessJournal of UrologyBladder Cancer: Epidemiology & Evaluation II (MP35)1 May 2024MP35-13 PREVALENCE, TRENDS, AND COSTS OF OFFICE-BASED AND AMBULATORY SURGERY CENTER-BASED DIAGNOSTIC CYSTOSCOPY IN THE UNITED STATES Nelson T. Kuete, Krishna Parikh, Dattatraya Patil, Vikram Narayan, Viraj Master, and Shreyas S. Joshi Nelson T. KueteNelson T. Kuete , Krishna ParikhKrishna Parikh , Dattatraya PatilDattatraya Patil , Vikram NarayanVikram Narayan , Viraj MasterViraj Master , and Shreyas S. JoshiShreyas S. Joshi View All Author Informationhttps://doi.org/10.1097/01.JU.0001009372.61513.54.13AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Diagnostic cystoscopies are usually performed in the outpatient setting including in-office and ambulatory surgery centers (ASC), and the cost depends on several factors such as the type of facility used. This study aimed to study trends in diagnostic cystoscopy procedures performed in office vs. ASC and analyze factors and costs associated with use in each venue. METHODS: We analyzed the number of uncomplicated cystoscopies (CPT 52000) between 2009 and 2021 in the MarketScan commercial claims (CCAE) and Medicare supplemental database (MDCR). Observed counts of procedures are reported per 100,000 eligible patients in each given year. Costs for CPT 52000 were inflation-adjusted for year 2021 for reporting. All comparisons were tested by Chi-square for categorical and Wilcoxon rank-sum test for continuous variables. RESULTS: Figure 1 compares the annual count of cystoscopies performed in the office vs. ASC per 100,000 enrollees and shows that for both CCAE and MDCR datasets, the number of cystoscopies performed in office has declined, whereas the number of procedures in ASCs has remained stable. In Table 1, the number of cystoscopies was classified by Charlson comorbidity index (CCI). Patients with CCI of >=3 were 19% (CCAE) and 5% (MDCR) more likely to have their procedure done in ASC. Table 2 shows that the cost of cystoscopy is always higher when performed in ASC. CONCLUSIONS: The number of cystoscopies in office has declined over time and may be the result of de-escalation of care or advances in clinical technology over time. Patients' CCI appears to correlate with the use of ASC. Given the higher cost of cystoscopy in ASC, the increasing proportion of ASC-based cystoscopies should prompt further research focusing on appropriate resource utilization for these procedures. Download PPT Source of Funding: Emory School of Medicine Department of Urology Research Fund © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e586 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Nelson T. Kuete More articles by this author Krishna Parikh More articles by this author Dattatraya Patil More articles by this author Vikram Narayan More articles by this author Viraj Master More articles by this author Shreyas S. Joshi More articles by this author Expand All Advertisement PDF downloadLoading ...